Open AccessIncreased All-Cause and Cancer Mortality in HTLV-II Infection
Author(s) -
Hope H. Biswas,
Zhanna Kaidarova,
George Garratty,
Joan Gibble,
Bruce Newman,
James W. Smith,
Alyssa Ziman,
Joy Fridey,
Ronald A. Sacher,
Edward L. Murphy
Publication year - 2010
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0b013e3181cc5481
Subject(s) - medicine , hazard ratio , cancer , cause of death , proportional hazards model , confounding , national death index , mortality rate , prospective cohort study , odds ratio , cohort study , immunology , confidence interval , disease
Human T-lymphotropic virus (HTLV)-I and HTLV-II cause chronic human retroviral infections, but few studies have examined the impact of either virus on survival among otherwise healthy individuals. The authors analyzed all-cause and cancer mortality in a prospective cohort of 155 HTLV-I, 387 HTLV-II, and 799 seronegative subjects.